Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Informa Life Sciences’ 7th Annual Veterinary Vaccines

05 Dec 2012 - 06 Dec 2012 - Brussels, Belgium



Bookmark and Share


Critical innovations and the latest technological advances in adjuvants and delivery platforms for veterinary vaccines

Informa Life Sciences’ 7th Annual Veterinary Vaccines conference has been specifically designed to provide you with critical innovations for identifying and responding to emerging diseases and regulatory feedback for veterinary vaccine registrations. Plus the latest technological advances in adjuvant, delivery platforms and cell expression systems from industry and academia to optimise your vaccine development programme. 

Conference Highlights include:

- Examine current & future perspectives for major veterinary vaccine targets & technological advances in vaccine development

- Gain strategic industry advice on the development and licensing strategies for next gen vet vaccines

- Improve your vaccine efficacy – Explore the latest breakthroughs in adjuvant technologies

- Understand the legislation and gain clarification on the technical requirements for the registration of advanced GMO vaccines in Europe direct from the Danish Health and Medicines Authority

…and many more!

Please quote CQ8132TECH when booking your place!

For more information and to download the conference brochure, please visit:  

http://www.informa-ls.com/CQ8132TECH




Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Monkeys Protected by Zika DNA Vaccine
Experimental Zika virus DNA vaccines successfully protected monkeys against Zika infection.
New Weapon Against Hard-to-Treat Bacterial Infections
Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Vaccine Against Common Cold Achievable
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
GSK’s Shingles Vaccine Candidate Shows High Efficacy
The vaccine candidate showed high efficacy against shingles and its complications in adults aged 70yrs+ in phase III study.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!